Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01676259
Title A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer (PROTACT)
Acronym PROTACT
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Silenseed Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR


No variant requirements are available.